Increased Expression of Angiogenic Genes in the Brains of Mouse Meg3-Null Embryos

被引：144

作者：

Gordon, Francesca E. ^{[1
]}

Nutt, Catherine L. ^{[2
]}

Cheunsuchon, Pornsuk ^{[1
]}

Nakayama, Yuki ^{[1
]}

Provencher, Katelyn A. ^{[1
,2
]}

Rice, Kimberley A.

Zhou, Yunli ^{[1
]}

Zhang, Xun ^{[1
]}

Klibanski, Anne ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA

来源：

ENDOCRINOLOGY | 2010年 / 151卷 / 06期

基金：

美国国家卫生研究院;

关键词：

ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; IMPRINTED GENE; PROMOTER REGION; HES GENES; VEGF; MEG3; ACTIVATION; HYPERMETHYLATION; PHOSPHORYLATION;

D O I：

10.1210/en.2009-1151

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Maternally expressed gene 3 (MEG3) is a noncoding RNA highly expressed in the normal human brain and pituitary. Expression of MEG3 is lost in gonadotroph-derived clinically nonfunctioning pituitary adenomas. Meg3 knockout mice were generated to identify targets and potential functions of this gene in embryonic development and tumorigenesis. Gene expression profiles were compared in the brains of Meg3-null embryos and wild-type littermate controls using microarray analysis. Microarray data were analyzed with GeneSifter, which uses Kyoto Encyclopedia of Genes and Genomes pathways and Gene Ontology classifications to identify signaling cascades and functional categories of interest within the dataset. Differences were found in signaling pathways and ontologies related to angiogenesis between wild-type and knockout embryos. Quantitative RTPCR and immunohistological staining showed increased expression of some Vascular Endothelial Growth Factor pathway genes and increased cortical microvessel density in the Meg3-null embryos. In conclusion, Meg3 may play an important role in control of vascularization in the brain and may function as a tumor suppressor in part by inhibiting angiogenesis. (Endocrinology 151: 2443-2452, 2010)

引用

页码：2443 / 2452

页数：10

共 55 条

[1] The pathogenesis of pituitary tumours [J].

Asa, SL ;

Ezzat, S .

NATURE REVIEWS CANCER, 2002, 2 (11) :836-849

[2] Gene Ontology: tool for the unification of biology [J].

Ashburner, M ;

Ball, CA ;

Blake, JA ;

Botstein, D ;

Butler, H ;

Cherry, JM ;

Davis, AP ;

Dolinski, K ;

Dwight, SS ;

Eppig, JT ;

Harris, MA ;

Hill, DP ;

Issel-Tarver, L ;

Kasarskis, A ;

Lewis, S ;

Matese, JC ;

Richardson, JE ;

Ringwald, M ;

Rubin, GM ;

Sherlock, G .

NATURE GENETICS, 2000, 25 (01) :25-29

[3] Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia:: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour [J].

Astuti, D ;

Latif, F ;

Wagner, K ;

Gentle, D ;

Cooper, WN ;

Catchpoole, D ;

Grundy, R ;

Ferguson-Smith, AC ;

Maher, ER .

BRITISH JOURNAL OF CANCER, 2005, 92 (08) :1574-1580

[4] Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma [J].

Benetatos, Leonidas ;

Dasoula, Aggeliki ;

Hatzimichael, Eleftheria ;

Georgiou, Ioannis ;

Syrrou, Maria ;

Bourantas, Konstantinos L. .

CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (03) :171-175

[5] Medical therapy for clinically non-functioning pituitary adenomas [J].

Colao, Annamaria ;

Di Somma, Carolina ;

Pivonello, Rosario ;

Faggiano, Antongiulio ;

Lombardi, Gaetano ;

Savastano, Silvia .

[6] Restricted co-expression of Dlk1 and the reciprocally imprinted non-coding RNA, Glk2:: Implications for cis-acting control [J].

da Rocha, Simao T. ;

Tevendale, Maxine ;

Knowles, Edward ;

Takada, Shuji ;

Watkins, Marie ;

Ferguson-Smith, Anne C. .

DEVELOPMENTAL BIOLOGY, 2007, 306 (02) :810-823

[7] Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma [J].

Dekkers, O. M. ;

de Keizer, R. J. W. ;

Roelfsema, F. ;

vd Klaauw, A. A. ;

Honkoop, P. J. ;

Van Dulken, H. ;

Smit, J. W. A. ;

Romijn, J. A. ;

Pereira, A. M. .

PITUITARY, 2007, 10 (01) :61-65

[8] The natural course of non-functioning pituitary macroadenomas [J].

Dekkers, O. M. ;

Hammer, S. ;

de Keizer, R. J. W. ;

Roelfsema, F. ;

Schutte, P. J. ;

Smit, J. W. A. ;

Romijn, J. A. ;

Pereira, A. M. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (02) :217-224

[9]

DeLisser HM, 1997, AM J PATHOL, V151, P671

[10] THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].

DEVRIES, C ;

ESCOBEDO, JA ;

UENO, H ;

HOUCK, K ;

FERRARA, N ;

WILLIAMS, LT .

SCIENCE, 1992, 255 (5047) :989-991

← 1 2 3 4 5 6 →